RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Artelo Biosciences Stock

Artelo Biosciences Employees 2024

Artelo Biosciences Employees

3

Ticker

ARTL

ISIN

US04301G2012

WKN

A2PNJU

In 2024, Artelo Biosciences employed 3 people, a 0% change from the 3 number of employees in the previous year.

Artelo Biosciences Aktienanalyse

What does Artelo Biosciences do?

Artelo Biosciences Inc is an innovative biopharmaceutical company specializing in the research and development of new therapies for the treatment of cancer and inflammatory diseases. The company was founded in 2011 and is headquartered in Manchester, UK, with a branch office in San Diego, USA. Artelo Biosciences Inc began with the discovery of new drug candidates based on the body's endocannabinoid system, which plays a crucial role in regulating various physiological processes such as pain, inflammation, mood, and appetite. The company's business model is based on identifying and researching new drug candidates based on the endocannabinoid system, as well as developing and marketing new therapies for the treatment of cancer and inflammatory diseases. Artelo Biosciences Inc operates in various sectors, including cancer therapy, inflammation inhibition, and neurological disorders. In cancer therapy, the company focuses on the development of new drugs for the treatment of solid tumors, particularly triple-negative breast cancer (TNBC), a highly aggressive type of cancer for which there are currently limited therapy options. Artelo Biosciences Inc has several promising drug candidates, including ART27.13, a synthetic cannabinoid receptor agonist that has shown in preclinical studies to inhibit the growth of TNBC cells. In inflammation inhibition, Artelo Biosciences Inc focuses on the development of new drugs for the treatment of diabetes, obesity, and inflammatory bowel diseases. The company has several promising drug candidates, including ART26.12, a synthetic endocannabinoid receptor agonist that has shown in preclinical studies to reduce inflammation in the intestine and improve insulin sensitivity. In neurological therapy, Artelo Biosciences Inc focuses on the development of new drugs for the treatment of anxiety and pain. The company has several promising drug candidates, including ART12.11, a synthetic endocannabinoid receptor agonist that has shown in preclinical studies to reduce anxiety and inhibit pain perception. Artelo Biosciences Inc closely collaborates with leading academic institutions and research centers to develop and test its drug candidates. The company has a strong research and development department composed of highly qualified scientists and clinicians. It also has an effective licensing and marketing strategy to bring its products to market. In summary, Artelo Biosciences Inc is an innovative biopharmaceutical company specializing in the research and development of new therapies for the treatment of cancer and inflammatory diseases. The company's business model is based on identifying and researching new drug candidates based on the endocannabinoid system, as well as developing and marketing new therapies. The company operates in various sectors, including cancer therapy, inflammation inhibition, and neurological disorders. Artelo Biosciences Inc has its own patents and licenses, a strong research and development department, and an effective licensing and marketing strategy to bring its products to market. Artelo Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Artelo Biosciences's Employee Base

Artelo Biosciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Artelo Biosciences's operational capacity and future potential.

Year-to-Year Comparison

Assessing Artelo Biosciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Artelo Biosciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Artelo Biosciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Artelo Biosciences stock

How many employees does Artelo Biosciences have this year?

Artelo Biosciences has 3 undefined employees this year.

How many employees did Artelo Biosciences have compared to the previous year?

Compared to the previous year, Artelo Biosciences had 0% more employees.

What impact did the number of employees have on the company Artelo Biosciences?

The number of employees has a direct impact on the efficiency and productivity of Artelo Biosciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Artelo Biosciences?

The number of employees can also have an impact on investors of Artelo Biosciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Artelo Biosciences affect the company?

An increase in equity of Artelo Biosciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Artelo Biosciences's equity affect the company?

A reduction in equity of Artelo Biosciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Artelo Biosciences?

Some factors that can influence the equity of Artelo Biosciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Artelo Biosciences so important for investors?

The equity of Artelo Biosciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Artelo Biosciences influence the company?

The number of employees at Artelo Biosciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Artelo Biosciences evolved in recent years?

In recent years, the number of employees at Artelo Biosciences has changed by 0.

How many employees does Artelo Biosciences currently have?

Artelo Biosciences currently has 3 undefined employees.

Why is the number of employees important for investors of Artelo Biosciences?

The number of employees is important for investors of Artelo Biosciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Artelo Biosciences take to change the number of employees?

To change the number of employees, Artelo Biosciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Artelo Biosciences pay?

Over the past 12 months, Artelo Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Artelo Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Artelo Biosciences?

The current dividend yield of Artelo Biosciences is .

When does Artelo Biosciences pay dividends?

Artelo Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Artelo Biosciences?

Artelo Biosciences paid dividends every year for the past 0 years.

What is the dividend of Artelo Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Artelo Biosciences located?

Artelo Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Artelo Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Artelo Biosciences from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Artelo Biosciences pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Artelo Biosciences in the year 2023?

In the year 2023, Artelo Biosciences distributed 0 USD as dividends.

In which currency does Artelo Biosciences pay out the dividend?

The dividends of Artelo Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Artelo Biosciences

Our stock analysis for Artelo Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Artelo Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.